1. Home
  2. BMRN vs AIZ Comparison

BMRN vs AIZ Comparison

Compare BMRN & AIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • AIZ
  • Stock Information
  • Founded
  • BMRN 1996
  • AIZ 1892
  • Country
  • BMRN United States
  • AIZ United States
  • Employees
  • BMRN N/A
  • AIZ N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • AIZ Property-Casualty Insurers
  • Sector
  • BMRN Health Care
  • AIZ Finance
  • Exchange
  • BMRN Nasdaq
  • AIZ Nasdaq
  • Market Cap
  • BMRN 12.1B
  • AIZ 10.1B
  • IPO Year
  • BMRN 1999
  • AIZ N/A
  • Fundamental
  • Price
  • BMRN $54.97
  • AIZ $196.84
  • Analyst Decision
  • BMRN Buy
  • AIZ Strong Buy
  • Analyst Count
  • BMRN 22
  • AIZ 6
  • Target Price
  • BMRN $93.43
  • AIZ $231.33
  • AVG Volume (30 Days)
  • BMRN 2.2M
  • AIZ 419.5K
  • Earning Date
  • BMRN 08-04-2025
  • AIZ 08-05-2025
  • Dividend Yield
  • BMRN N/A
  • AIZ 1.62%
  • EPS Growth
  • BMRN 152.82
  • AIZ N/A
  • EPS
  • BMRN 2.71
  • AIZ 12.82
  • Revenue
  • BMRN $2,950,227,000.00
  • AIZ $12,071,400,000.00
  • Revenue This Year
  • BMRN $12.23
  • AIZ $6.89
  • Revenue Next Year
  • BMRN $9.99
  • AIZ $4.49
  • P/E Ratio
  • BMRN $20.28
  • AIZ $15.42
  • Revenue Growth
  • BMRN 19.36
  • AIZ 6.18
  • 52 Week Low
  • BMRN $52.93
  • AIZ $160.12
  • 52 Week High
  • BMRN $94.85
  • AIZ $230.55
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 40.74
  • AIZ 47.82
  • Support Level
  • BMRN $53.76
  • AIZ $193.94
  • Resistance Level
  • BMRN $56.25
  • AIZ $200.18
  • Average True Range (ATR)
  • BMRN 1.26
  • AIZ 3.70
  • MACD
  • BMRN 0.06
  • AIZ -0.40
  • Stochastic Oscillator
  • BMRN 28.09
  • AIZ 31.12

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About AIZ Assurant Inc.

Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.

Share on Social Networks: